All Q3 FY26 results →
M

Marico

Q3 FY26Agricultural Food & other Products

Marico Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹849
Market cap₹1.1L Cr
P/E59.5
Updated23 Aug 2026
Read4 min read

The short version

Foods revenue expected to reach 9x of FY20 levels next year and 15x by FY30. Marico aims for a CAGR of 13%-14% in growth over the next five years, targeting a doubling of business.

From Marico's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Foods revenue expected to reach 9x of FY20 levels next year and 15x by FY30.
  • Digital-first premium personal care (PPC) annual run rate aimed to be 5x of FY24 levels by FY30.
  • All digital brands globally projected to collectively reach around INR4,000 crores top line by FY30.
  • New businesses to form about 33% of India revenues by FY30, reflecting strategic diversification.
  • Mid-teens operating profit growth guidance maintained at a group level, despite acquisitions.
  • Brands like 4700BC targeted to become EBITDA positive within 12-18 months and achieve mid-to-high single-digit EBITDA margins in 3 years.

2 more points from Marico's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Marico said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • No specific future acquisitions are detailed, but the company remains open to "tuck-in" opportunities and selective expansions, particularly in mass foods and digital personal care.
  • The focus is on profitable scale-up with a minimum INR100-150 crore scale to rapidly grow brands 4x to 5x without losses.
  • Investments in centralized capabilities are ongoing, including building in-house supply chain, content, and digital marketing expertise to support rapid growth.
  • Integration includes operational investments such as bringing some products in-house to improve gross margins (e.g., Beardo).
  • Synergies across distribution, procurement, and media buying reduce overall cost and enhance efficiency.

2 more points from Marico's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Agricultural Food & other Products

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 2
2TBI Corn
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Marico said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript document for Marico Limited does not contain any information regarding the company's current or expected orderbook or pending orders. The discussion primarily revolves around strategic investments, acquisitions, digital-first growth strategies, portfolio expansion in foods and personal care, margin guidance, and integration of acquired brands. No data or remarks related to orderbook status or pending orders are mentioned in the transcript.

Marico — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹3.3K Cr, net profit ₹408 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Agricultural Food & other Products this season

  • Modi Naturals (Q3 FY26)

    174.1 crore, down 2.8% YoY from Rs. Key investor presentation takeaways from Modi Naturals Ltd's Q3 FY26 investor presentation — and how it ranks against sector

  • Uttam Sug.Mills (Q3 FY26)

    523.27 Cr. Key investor presentation takeaways from Uttam Sugar Mills Ltd's Q3 FY26 investor presentation — and how it ranks against sector peers.

  • GRM Overseas Ltd (Q3 FY26)

    482.8 Crores . Key investor presentation takeaways from GRM Overseas Ltd's Q3 FY26 investor presentation — and how it ranks against sector peers.

  • Nath Bio-Genes (Q3 FY26)

    Q3FY26 Revenue: INR 660 Mn, up 79% YoY from INR 369 Mn in Q3FY25 (Page 24) . Key investor presentation takeaways from Nath Bio-Genes (India) Ltd's Q3 FY26 inves

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Marico and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Marico Q3 FY26 results?

Foods revenue expected to reach 9x of FY20 levels next year and 15x by FY30. Marico aims for a CAGR of 13%-14% in growth over the next five years, targeting a doubling of business.

What is Marico share price analysis?

Marico currently shows a neutral. The stock trades at a P/E of 59.5 with a market cap of ₹112,337 Cr. Investors should review the full earnings analysis for detailed insights.

Is Marico planning capital expenditure?

No specific future acquisitions are detailed, but the company remains open to "tuck-in" opportunities and selective expansions, particularly in mass foods and digital personal care.

Keep Marico on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.